Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,811.44
(
0.44%
)
News Focus
News Focus
Post# of 822798
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Dr Bala

Send PM Follow Ignore
Followers 98
Posts 7202
Boards Moderated 0
Alias Born 03/29/2019

Dr Bala

Re: HyGro post# 547020

Saturday, 12/10/2022 2:54:23 PM

Saturday, December 10, 2022 2:54:23 PM

Post# of 822798
Wrong. From the JTM 2018 paper:

All patients were allowed to receive DCVax-L following
tumor progression/recurrence, as well as other approved
treatments per local practice.



From the JAMA results, best option would have been DCVax-L.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News